Pubblicazioni

Impact of donor-derived CD34+infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT

2022 - BONE MARROW TRANSPLANTATION

Czerw, T; Iacobelli, S; Malpassuti, V; Koster, L; Kroger, N; Robin, M; Maertens, J; Chevallier, P; Watz, E; Poire, X; Snowden, Ja; Kuball, J; Kinsella, F; Blaise, D; Remenyi, P; Mear, Jb; Cammenga, J; Rubio, Mt; Maury, S; Daguindau, E; Finnegan, D; Hayden, P; Hernandez-Boluda, Jc; Mclornan, D; Yakoub-Agha, I

Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT

2021 - BRITISH JOURNAL OF HAEMATOLOGY

Shimoni, A; Robin, M; Iacobelli, S; Beelen, D; Mufti, Gj; Ciceri, F; Bethge, W; Volin, L; Blaise, D; Ganser, A; Luft, T; Chevallier, P; Schwerdtfeger, R; Koster, L; de Witte, T; Kroger, N; Nagler, A; Yakoub-Agha, I

Identification of New Soluble Factors Correlated With the Development of Graft Failure After Haploidentical Hematopoietic Stem Cell Transplantation

2020 - FRONTIERS IN IMMUNOLOGY

Weber, G.; Strocchio, L.; Del Bufalo, F.; Algeri, M.; Pagliara, D.; Arnone, C. M.; De Angelis, B.; Quintarelli, C.; Locatelli, F.; Merli, P.; Caruana, I.